Difficulty: Medium
Average Score: 89%
Practice
Which of the following was the most likely cause of the patient's disorder?
Correct answer
C
Rationale
In this Pharmacology Quizlet question, the correct answer is C) Genetic polymorphism of CYP2C9. This is because genetic variations in the CYP2C9 gene can affect the metabolism of warfarin, a commonly used anticoagulant.
Option A, increased protein binding of warfarin, is unlikely to be the cause of the patient's disorder as warfarin's protein binding typically remains relatively constant.
Option B, decreased renal excretion of warfarin, is not the primary mechanism of warfarin metabolism, so it is less likely to be the main cause of the disorder.
Option D, decreased metabolism of CYP2C9, is also incorrect because it is the genetic polymorphism of CYP2C9, rather than a decrease in metabolism, that leads to altered warfarin clearance in individuals.
Educationally, understanding how genetic variations can impact drug metabolism is crucial in pharmacology as it helps healthcare professionals personalize drug therapy to optimize outcomes and minimize adverse effects for individual patients. It underscores the importance of pharmacogenomics in clinical practice and highlights the need for tailored treatment approaches based on genetic factors.
Option A, increased protein binding of warfarin, is unlikely to be the cause of the patient's disorder as warfarin's protein binding typically remains relatively constant.
Option B, decreased renal excretion of warfarin, is not the primary mechanism of warfarin metabolism, so it is less likely to be the main cause of the disorder.
Option D, decreased metabolism of CYP2C9, is also incorrect because it is the genetic polymorphism of CYP2C9, rather than a decrease in metabolism, that leads to altered warfarin clearance in individuals.
Educationally, understanding how genetic variations can impact drug metabolism is crucial in pharmacology as it helps healthcare professionals personalize drug therapy to optimize outcomes and minimize adverse effects for individual patients. It underscores the importance of pharmacogenomics in clinical practice and highlights the need for tailored treatment approaches based on genetic factors.